Clinical Trial : Complications of in the Bag IOL Versus Optic Capture of IOL in Pediatric Cataract Surgery
NCT ID: NCT02491918
Last Updated: 2015-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2013-04-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contrast Sensitivity Assessment in Pediatric Cataract Surgery With IOL Implantation
NCT01901744
Aphakia Versus Pseudophakia in Children Under 2 Years Undergoing Bilateral Congenital Cataract Surgery
NCT01297153
Corneal Endothelial Changes Following Pediatric Cataract Surgery With IOL Implantation
NCT01504607
Optic Capture Without Anterior Vitrectomy in Pediatric Cataract Surgery
NCT05461040
Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During Phacoemulsification
NCT01664689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. in the bag IOL with limbal anterior vitrectomy
2. posterior optic capture of IOL optic through the posterior capsulorhexis without any vitrectomy.
The aim is to evaluate whether avoiding anterior vitrectomy is a feasible option, particularly younger children, where anterior vitrectomy has become an integral part of the routine surgical strategy.
All children will be evaluated at 1 month, 3 months, 6 months and 12 months postoperatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
In the bag IOL
Cataract surgery with IOL implantation in the capsular bag
cataract surgery
cataract surgery in children
Intraocular lens implantation
intraocular lens implantation in the capsular bag or optic capture
Optic Capture of IOL
intraocular lens implantation in the capsular bag with posterior optic capture
cataract surgery
cataract surgery in children
Intraocular lens implantation
intraocular lens implantation in the capsular bag or optic capture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cataract surgery
cataract surgery in children
Intraocular lens implantation
intraocular lens implantation in the capsular bag or optic capture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* unilateral or bilateral cataract,
* corneal diameter \>9.0mmHg
Exclusion Criteria
* uveitis,
* ocular comorbidity,
* microphthalmos,
* microcornea,
* parents not consenting to participate in study,
* traumatic cataract
15 Days
4 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iladevi Cataract and IOL Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abhay R. Vasavada
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
abhay vasavada, MS,FRCS
Role: STUDY_DIRECTOR
Iladevi Cataract & IOL Research Centre, Ahmedabad, India
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013 Research Foundation Grant
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
13-009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.